Hallam Trevor 4
4 · SUTRO BIOPHARMA, INC. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Hallam Trevor
Chief Science Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-27+5,250→ 85,521 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2023-01-27−5,250→ 5,250 totalExp: 2024-01-29→ Common Stock (5,250 underlying) - Tax Payment
Common Stock
2023-01-27$7.50/sh−2,140$16,050→ 83,381 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date.